Keywords: ایمونوتراپی; HPV; human papilloma virus; CC; cervical cancer; EC; endometrial cancer; CIN; cervical intraepithelial neoplasia; VIN; vulvar intraepithelial neoplasia; VaIN; vaginal intraepithelial neoplasia; CTLA-4; cytotoxic T-lymphocyte-associated antigen 4; PD-1; pr
مقالات ISI ایمونوتراپی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمونوتراپی; Brain neoplasm; Clinical trials; Glioblastoma; Immunotherapeutic; Immunotherapy; Vaccine; APC; Antigen-presenting cell; APVAC; Actively personalized vaccination; BBB; Blood-brain barrier; CMV; Cytomegalovirus; CNS; Central nervous system; CSF; Cerebrosp
Keywords: ایمونوتراپی; oncology; cancer; oncologic emergencies; checkpoint inhibitor; toxicity; toxicities; chemotherapy; immunotherapy; pneumonitis; colitis; thyroiditis; hypophysitis; dermatitis; immune checkpoint inhibitor; immunotherapy-related adverse events; irAEs; ICPI;
Keywords: ایمونوتراپی; Radiotherapy; Immunotherapy; Anti-tumor immunity; Abscopal effect; Immunogenic cell death; Radiothérapie; Immunothérapie; Immunité anti tumorale; Effet abscopal; Mort cellulaire immunogène;
Keywords: ایمونوتراپی; urinary bladder neoplasms; carcinoma; programmed cell death 1 receptor; immunotherapy; APC; antigen-presenting cell; BCG; bacillus Calmette-Guérin; CD; cluster of differentiation; CR; complete response; CTLA-4; cytotoxic T-lymphocyte-associated antigen-4
Keywords: ایمونوتراپی; Glioblastoma; MGMT; Repositioning of drugs; Precision medicine; Biomarker; Radiomics; Treatment resistance; Immunotherapy;
Keywords: ایمونوتراپی; Phenotypic switching; Reversibility; Somatic evolution; Intratumoral heterogeneity; Immunotherapy; Drug resistance;
Keywords: ایمونوتراپی; Malignant pleural mesothelioma; Oncology therapeutics; Biomarkers; Immunotherapy; Chemotherapy;
Keywords: ایمونوتراپی; DC-CIK; dendritic cell vaccine; hepatocellular carcinoma; immunotherapy; meta-analysis;
Keywords: ایمونوتراپی; Neuroregression; Encephalitis; Brain atrophy; Interferonopathy; Neopterins; Dystonia; Spasticity; Bulbar palsy; Speech regression; Motor regression; Immunotherapy; Neurodegeneration; Innate immune system;
Keywords: ایمونوتراپی; Colorectal cancer; Clinical trials; KRAS; BRAF; Her2; Immunotherapy;
Keywords: ایمونوتراپی; Immunotherapy; Gynecologic Cancers; CTLA-4 Inhibitors; PD1/PDL1 Inhibitors; Toxicity Management;
Keywords: ایمونوتراپی; Chemotherapy; Immunotherapy; Metastasis; Renal cell carcinoma; Sarcomatoid;
Keywords: ایمونوتراپی; Tuberculosis; Lung cancer; Chemotherapy; Immunotherapy; Immune checkpoint inhibitors;
Keywords: ایمونوتراپی; Epigenetic therapy; Gene reactivation; Immunotherapy; Decitabine; Transplantation;
Keywords: ایمونوتراپی; PD-1; PD-L1; Immunotherapy; Checkpoint inhibitors; Biomarkers; Non-small cell lung cancer; Tumor mutational burden; Microbiome;
Keywords: ایمونوتراپی; Brain; Metastasis; Immunotherapy; CTLA4; PD1/PDL1; Biomarkers;
Keywords: ایمونوتراپی; Thoracic oncology; Advances in 2017; Immunotherapy; Target therapy; Thoracic; malignancies;
Keywords: ایمونوتراپی; Immunotherapy; Chemotherapy; Doxorubicin; Recombinant polypeptide; Nanoparticle; Polymer conjugate; Doxorubicin (PubChem CID: 31703);
Keywords: ایمونوتراپی; Autoantibody; Inhibitory synapse; GABA; Glycin; Amphiphysin; Immunotherapy;
Keywords: ایمونوتراپی; Immunoengineering; Gene delivery; Vaccines; Immunotherapy; Polymers;
Keywords: ایمونوتراپی; Immunotherapy; Nanovaccine; OVA; CpG; Hyaluronidase; PEI;
Keywords: ایمونوتراپی; Locally advanced NSCLC; Radiochemotherapy; Consolidation therapy; Chemotherapy; Targeted therapy; Immunotherapy;
Keywords: ایمونوتراپی; ARID; Age Related Immune Differences; CD40L; CD40 ligand; CTLA-4; cytotoxic T lymphocyte antigen-4; IL; interleukin; Lag3; lymphocyte activation gene 3; MDSC; myeloid derived suppressor cell; MHC; major histocompatibility complex; mTOR; mammalian target o
Keywords: ایمونوتراپی; Immunotherapy; toxicity; checkpoint inhibition; immune-related adverse events;
Keywords: ایمونوتراپی; Immunotherapy; Nanocomposite; Anticancer; Pectin; Guar gum;
Keywords: ایمونوتراپی; CAP; Oropharynx cancer; Immunotherapy; Apoptosis; ROS/RNS;
Keywords: ایمونوتراپی; Silicon nanoparticles (SiNPs); Gold nanoparticles (GNPs); Iron oxide nanoparticles (IONPs); Carbon nanotube (CNT); Immunotherapy;
Keywords: ایمونوتراپی; Neuromyelitis optica; Vaccines; Risk factors; Aquaporin 4; Immunotherapy;
Keywords: ایمونوتراپی; Toxicity; Efficacy; Pharmacokinetics; Pharmacogenetics; Modeling; Immunotherapy; Adherence;
Keywords: ایمونوتراپی; Neurologic complications; Neurotoxicity; Chemotherapy; Targeted agents; Immunotherapy;
Keywords: ایمونوتراپی; AEs; adverse events; EMT/MET; epithelial-mesenchymal transition/mesenchymal-epithelial transition; LPS; liposarcoma; LVEF; left ventricular ejection fraction; STS; soft-tissue sarcomas; Sarcoma; Metastatic disease; Chemotherapy; Epigenetics; Targeted ther
Keywords: ایمونوتراپی; 5-FU; 5-fluoro-uracil; AAV; adeno-associated virus; ADAM; ADAM metallopeptidase domain; ADCC; antibody-dependent cell-mediated cytotoxicity; CCL; chemokine (C-C motif) ligand; CD; cluster of differentiation; CTLA-4; cytotoxic T-lymphocyte-associated ant
Keywords: ایمونوتراپی; Mass cytometry; AML; Microenvironment; Immunotherapy;
Keywords: ایمونوتراپی; Colorectal cancer; Immunotherapy; Tumor microenvironment; Genomics; Biomarker; Personalized medicine; Clinical trials;
Keywords: ایمونوتراپی; Head and neck; Recurrent/metastatic disease; Immunotherapy; Immune checkpoint inhibitors;
Keywords: ایمونوتراپی; Immune dysregulation; Severe trauma; Immunotherapy; Tissue regeneration; Immunosuppression; Animal models;
Keywords: ایمونوتراپی; asthma; critical care; pregnancy; primary medicine; ACQ; Asthma Control Questionnaire; ACT; Asthma Control Test; ECCO2R; extracorporeal carbon dioxide removal; ECMO; extracorporeal membrane oxygenation; ICS; inhaled corticosteroid; IT; immunotherapy; LABA
Keywords: ایمونوتراپی; Radiation therapy; Immunotherapy; Renal cell carcinoma;
Keywords: ایمونوتراپی; Anemia; Antibody interference; CD38; Immunotherapy; Indirect antiglobulin test;
Keywords: ایمونوتراپی; HPV; Cervical cancer; Dendritic cells; Therapeutic vaccines; Immune suppression; Clinical trials; Immunotherapy;
Keywords: ایمونوتراپی; Head and neck cancer; Nasopharynx cancer; Immunotherapy; PD-L1; Immune checkpoint; HPV; EBV;
Keywords: ایمونوتراپی; Clinical outcome; Radiofrequency ablation; Hepatocellular carcinoma; Alpha-fetoprotein; microRNAs; PD-L1; Nivolumab; Tremelimumab; Immunotherapy; Circulating miRNAs;
Keywords: ایمونوتراپی; Non-small-cell lung cancer; Immunotherapy; Combination therapy; Cancer biology; Systems biology;
Keywords: ایمونوتراپی; Cancer; HCC; Immunotherapy;
Keywords: ایمونوتراپی; GBM; Glioblastoma multiforme; CARs; chimeric antigen receptors; PDL1; programmed death ligand 1; IDH1; isocitrate dehydrogenase 1; PMN; polymorphonuclear; TAMs; tumor associated macrophages; HLA; human leucocyte antigen; FLT3L; Fms-like tyrosine kinase 3
Keywords: ایمونوتراپی; Thermosensitive polymer; Nanophase segregation; Immune checkpoint; Cancer; Immunotherapy;
Keywords: ایمونوتراپی; Nanoparticles; Immunotherapy; Antigen delivery; Adjuvant delivery; Immune checkpoint;
Keywords: ایمونوتراپی; ARID; Age Related Immune Dysfunction; BCG; Bacille Calmette-Guérin; CAR; chimeric antigen receptor; CDMRP; Congressionally Directed Medical Research Program; CD40L; CD40 ligand; CpG; poly-(cysteine 5â² to guanine); CRISPR; clustered regularly interspace
Keywords: ایمونوتراپی; Nanoparticles; Immunotherapy; Delivery system; Tumor microenvironment; Therapeutic cancer vaccines;